The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Shoaib, Muhammad, Dr
    Physician born in September 1978
    Individual (18072 offsprings)
    Officer
    2010-10-27 ~ now
    OF - Director → CIF 0
    Dr Muhammad Shoaib
    Born in September 1978
    Individual (18072 offsprings)
    Person with significant control
    2016-04-07 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
  • 2
    Shoaib, Nosheen
    Director born in July 1980
    Individual (2 offsprings)
    Officer
    2010-10-27 ~ now
    OF - Director → CIF 0
    Nosheen Shoaib
    Born in July 1980
    Individual (2 offsprings)
    Person with significant control
    2017-07-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

ALLIANCE DRUG DEVELOPMENT LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Average Number of Employees
02022-11-01 ~ 2023-10-31
32021-11-01 ~ 2022-10-31
Par Value of Share
Class 1 ordinary share
12022-11-01 ~ 2023-10-31
Class 2 ordinary share
12022-11-01 ~ 2023-10-31
Class 3 ordinary share
12022-11-01 ~ 2023-10-31
Property, Plant & Equipment
15,263 GBP2023-10-31
14,940 GBP2022-10-31
Fixed Assets - Investments
28 GBP2023-10-31
28 GBP2022-10-31
Fixed Assets
15,291 GBP2023-10-31
14,968 GBP2022-10-31
Total Inventories
48,744 GBP2023-10-31
15,120 GBP2022-10-31
Debtors
817,654 GBP2023-10-31
513,148 GBP2022-10-31
Cash at bank and in hand
114,050 GBP2023-10-31
573,748 GBP2022-10-31
Current Assets
980,448 GBP2023-10-31
1,102,016 GBP2022-10-31
Creditors
Current
328,380 GBP2023-10-31
449,885 GBP2022-10-31
Net Current Assets/Liabilities
652,068 GBP2023-10-31
652,131 GBP2022-10-31
Total Assets Less Current Liabilities
667,359 GBP2023-10-31
667,099 GBP2022-10-31
Net Assets/Liabilities
666,029 GBP2023-10-31
664,262 GBP2022-10-31
Equity
Called up share capital
650 GBP2023-10-31
650 GBP2022-10-31
Retained earnings (accumulated losses)
665,379 GBP2023-10-31
663,612 GBP2022-10-31
Equity
666,029 GBP2023-10-31
664,262 GBP2022-10-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
40,965 GBP2023-10-31
33,314 GBP2022-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
25,702 GBP2023-10-31
18,373 GBP2022-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
7,329 GBP2022-11-01 ~ 2023-10-31
Property, Plant & Equipment
Plant and equipment
15,263 GBP2023-10-31
14,941 GBP2022-10-31
Value of work in progress
48,744 GBP2023-10-31
15,120 GBP2022-10-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
8,910 GBP2023-10-31
1,536 GBP2022-10-31
Other Debtors
Current, Amounts falling due within one year
808,744 GBP2023-10-31
511,612 GBP2022-10-31
Debtors
Current, Amounts falling due within one year
817,654 GBP2023-10-31
513,148 GBP2022-10-31
Trade Creditors/Trade Payables
Current
1,257 GBP2023-10-31
2,220 GBP2022-10-31
Other Taxation & Social Security Payable
Current
31,050 GBP2023-10-31
85,673 GBP2022-10-31
Other Creditors
Current
296,073 GBP2023-10-31
361,992 GBP2022-10-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
1,330 GBP2023-10-31
2,837 GBP2022-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
300 shares2023-10-31
Class 2 ordinary share
300 shares2023-10-31
Class 3 ordinary share
50 shares2023-10-31
Related profiles found in government register
  • ALLIANCE DRUG DEVELOPMENT LIMITED
    Info
    Registered number 07420683
    Venture House 2 Arlington Square, Downshire Way, Bracknell RG12 1WA
    Private Limited Company incorporated on 2010-10-27 (14 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-27
    CIF 0
  • ALLIANCE DRUG DEVELOPMENT LTD
    S
    Registered number missing
    Office 13 Rockware Business Centre, 5 Rockware Avenue, Greenford, England, UB6 0AA
    Ltd Company
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • 393 Lordship Lane, London, United Kingdom
    Dissolved Corporate (2 parents)
    Equity (Company account)
    -65,250 GBP2017-11-30
    Person with significant control
    2016-11-26 ~ dissolved
    CIF 1 - Ownership of shares – More than 25% but not more than 50% → OE

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.